Uric Acid is a Useful Tool to Predict Contrast-Induced Nephropathy

Angiology

Volumn 68, Issue 7, 2017, Pages 627-632

  Mendi, Mehmet Ali ^a   Afsar, Baris ^b   Oksuz, Fatih ^a   Turak, Osman ^a   Yayla, Cagri ^a   Ozcan, Firat ^a   Johnson, Richard J ^c   Kanbay, Mehmet ^d  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d KOÇ UNIVERSITY   (Turkey)

Author keywords

contrast induced nephropathy; myocardial infarction; primary percutaneous coronary intervention; uric acid

Indexed keywords

C REACTIVE PROTEIN; CREATININE; URIC ACID; CONTRAST MEDIUM;

ADULT; ARTICLE; COLORIMETRY; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; DIABETES MELLITUS; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; KIDNEY DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; MORBIDITY; NEPHELOMETRY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; AGED; BLOOD; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA;

AGED; CONTRAST MEDIA; CREATININE; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTORS; URIC ACID; VENTRICULAR FUNCTION, LEFT;

EID: 85021794142     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319716639187     Document Type: Article

References (37)

1. McCullough PA,. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008; 51 (15): 1419-1428.
2. Kanbay M, Covic A, Coca SG, Turgut F, Akcay A, Parikh CR,. Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol. 2009; 41 (3): 617-627.
3. Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP,. Contrast-Induced Nephropathy: An "All or None" Phenomenon? Angiology. 2015; 66 (6): 508-513.
4. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44 (7): 1393-1399.
5. Goldenberg I, Matetzky S,. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005; 172 (11): 1461-1471.
6. Kanbay M, Solak Y, Dogan E, Lanaspa MA, Covic A,. Uric acid in hypertension and renal disease: the chicken or the egg? Blood Purif. 2010; 30 (4): 288-295.
7. Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ,. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013; 99 (11): 759-766.
8. Kanbay M, Ikizek M, Solak Y, et al. Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease. Am J Nephrol. 2011; 33 (4): 325-331.
9. Kanbay A, Inonu H, Solak Y, et al. Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome. Eur J Intern Med. 2014; 25 (5): 471-476.
10. Turak O, Afsar B, Ozcan F, et al. Relationship between elevated morning blood pressure surge, uric acid, and cardiovascular outcomes in hypertensive patients. J Clin Hypertens (Greenwich). 2014; 16 (7): 530-535.
11. Kanbay M, Jensen T, Solak Y, et al. Uric acid in metabolic syndrome: from an innocent bystander to a central player [published online December 15, 2015]. Eur J Intern Med. 2015.
12. Takir M, Kostek O, Ozkok A, et al. Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia. J Investig Med. 2015; 63 (8): 924-929.
13. Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S,. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv. 2006; 67 (2): 227-235.
14. Barbieri L, Verdoia M, Schaffer A, et al.Novara Atherosclerosis Study Group (NAS). Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI. Nutr Metab Cardiovasc Dis. 2015; 25 (2): 181-186.
15. Liu Y, Tan N, Chen J, et al. The relationship between hyperuricemia and the risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with relatively normal serum creatinine. Clinics (Sao Paulo). 2013; 68 (1): 19-25.
16. Toprak O, Cirit M, Yesil M, et al. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant. 2007; 22 (3): 819-826.
17. Elbasan Z, Sahin DY, Gur M, et al. Contrast-induced nephropathy in patients with ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Angiology. 2014; 65 (1): 37-42.
18. Karabulut A, Sahin I, Ilker Avci I, et al. Impact of serum alkaline phosphatase level on the pathophysiologic mechanism of contrast-induced nephropathy. Kardiol Pol. 2014; 72 (10): 977-982.
19. Kowalczyk J, Francuz P, Swoboda R, et al. Prognostic significance of hyperuricemia in patients with different types of renal dysfunction and acute myocardial infarction treated with percutaneous coronary intervention. Nephron Clin Pract. 2010; 116 (2): c114-c122.
20. Saritemur M, Turkeli M, Kalkan K, Tanboga IH, Aksakal E,. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED. Am J Emerg Med. 2014; 32 (2): 119-123.
21. Park SH, Shin WY, Lee EY, et al. The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention. Circ J. 2011; 75 (3): 692-697.
22. Guo W, Liu Y, Chen JY, et al. Hyperuricemia Is an Independent Predictor of Contrast-Induced Acute Kidney Injury and Mortality in Patients Undergoing Percutaneous Coronary Intervention. Angiology. 2015; 66 (8): 721-726.
23. Morcos SK, Thomsen HS, Webb JA,. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol. 1999; 9 (8): 1602-1613.
24. Nicola R, Shaqdan KW, Aran K, Mansouri M, Singh A, Abujudeh HH,. Contrast-Induced Nephropathy: Identifying the Risks, Choosing the Right Agent, and Reviewing Effective Prevention and Management Methods. Curr Probl Diagn Radiol. 2015; 44 (6): 501-504.
25. Bhatt H, Turkistani A, Sanghani D, Julliard K, Fernaine G,. Do Cardiovascular Risk Factors and Coronary SYNTAX Score Predict Contrast Volume Use During Cardiac Catheterization? Angiology. 2015; 66 (10): 933-940.
26. Erol T, Tekin A, Katircibasi MT, et al. Efficacy of allopurinol pretreatment for prevention of contrast-induced nephropathy: a randomized controlled trial. Int J Cardiol. 2013; 167 (4): 1396-1399.
27. Kumar A, Bhawani G, Kumari N, Murthy KS, Lalwani V, Raju Ch N,. Comparative study of renal protective effects of allopurinol and N-acetyl-cysteine on contrast induced nephropathy in patients undergoing cardiac catheterization. J Clin Diagn Res. 2014; 8 (12): hc03-hc07.
28. Kelley WN,. Uricosuria and x-ray contrast agents. N Engl J Med. 1971; 284 (17): 975-976.
29. Postlethwaite AE, Kelley WN,. Uricosuric effect of radiocontrast agents. A study in man of four commonly used preparations. Ann Intern Med. 1971; 74 (6): 845-852.
30. Schepers MS, van Ballegooijen ES, Bangma CH, Verkoelen CF,. Crystals cause acute necrotic cell death in renal proximal tubule cells, but not in collecting tubule cells. Kidney Int. 2005; 68 (4): 1543-1553.
31. Ejaz AA, Alquadan KF, Dass B, Shimada M, Kanbay M, Johnson RJ,. Effects of Serum Uric Acid on Estimated GFR in Cardiac Surgery Patients: A Pilot Study. Am J Nephrol. 2015; 42 (6): 402-409.
32. Ryu ES, Kim MJ, Shin HS, et al. Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease. Am J Physiol Renal Physiol. 2013; 304 (5): f471-f480.
33. Kanbay M, Huddam B, Azak A, et al. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011; 6 (8): 1887-1894.
34. Kanbay M, Siriopol D, Nistor I, et al. Effects of allopurinol on endothelial dysfunction: a meta-analysis. Am J Nephrol. 2014; 39 (4): 348-356.
35. Aykas F, Solak Y, Erden A, et al. Persistence of cardiovascular risk factors in women with previous preeclampsia: a long-term follow-up study. J Investig Med. 2015; 63 (4): 641-645.
36. Kanbay M, Yilmaz MI, Sonmez A, et al. Serum uric acid independently predicts cardiovascular events in advanced nephropathy. Am J Nephrol. 2012; 36 (4): 324-331.
37. Kang DH, Park SK, Lee IK, Johnson RJ,. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005; 16 (12): 3553-3562.